Utama › Kardiomiopati Hipertrofik › Pennsylvania
Kajian klinikal Kardiomiopati Hipertrofik di Pennsylvania
3 kajian untuk Kardiomiopati Hipertrofik sedang mencari peserta di lokasi di Pennsylvania.
Teks kajian rasmi (Bahasa Inggeris)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's University Health Network, Bethlehem
- University Of Pittsburgh, Pittsburgh
- Geisinger Health System, Wilkes-Barre
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Philadelphia
- Imbria Investigational Site, Philadelphia
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
Umur 8 ke atas · Lelaki · Dikemas kini 4 Mei 2026 · NCT06092034Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.